UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiretroviral therapy: current drugs

Infectious disease clinics of North America, 2014-09, Vol.28 (3), p.371-402

2014

Volltextzugriff (PDF)

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antibacterial Agents

Clinical pharmacokinetics, 2011-10, Vol.50 (10), p.637-664

2011

Volltextzugriff (PDF)

Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis

Annals of the rheumatic diseases, 2021-03, Vol.80 (3), p.406-408

2021

Volltextzugriff (PDF)

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine

Clinical infectious diseases, 2018-07, Vol.67 (2), p.193-201

2018

Volltextzugriff (PDF)

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents

Clinical pharmacokinetics, 2011-11, Vol.50 (11), p.689-704

2011

Volltextzugriff (PDF)

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

The international journal of neuropsychopharmacology, 2020-07, Vol.23 (7), p.417-425

2020

Volltextzugriff (PDF)

Management of Antiretrovirals in Critically Ill Patients: Great Progress But Potential Pitfalls

Critical care medicine, 2018-05, Vol.46 (5), p.663-665

2018

Volltextzugriff (PDF)

Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort

Clinical infectious diseases, 2020-12, Vol.71 (10), p.e604-e613

2020

Volltextzugriff (PDF)

Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy

AIDS care, 2021-11, Vol.33 (11), p.1507-1513

2021

Volltextzugriff (PDF)

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.193-200

2021

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine

Journal of acquired immune deficiency syndromes (1999), 2023-12, Vol.94 (5), p.468-473

2023

Volltextzugriff (PDF)

The Effect of GS‐548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS‐6637 in Healthy Adults

Journal of clinical pharmacology, 2020-12, Vol.60 (12), p.1598-1605

2020

Volltextzugriff (PDF)

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e002097

2021

Volltextzugriff (PDF)

Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

Neuropsychopharmacology (New York, N.Y.), 2020-07, Vol.45 (8), p.1405-1405

2020

Volltextzugriff (PDF)

Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products

Expert review of clinical pharmacology, 2017-01, Vol.10 (1), p.59-79

2017

Volltextzugriff (PDF)

Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers

Circulation (New York, N.Y.), 2016-12, Vol.134 (23), p.1909-1911

2016

Volltextzugriff (PDF)

Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV‐Infected Patient Following Oral and Jejunostomy‐Tube Administration

Pharmacotherapy, 2017-08, Vol.37 (8), p.e82-e89

2017

Volltextzugriff (PDF)

Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?

Journal of clinical pharmacology, 2018-03, Vol.58 (3), p.332-339

2018

Volltextzugriff (PDF)

National survey on continuous and extended infusions of antibiotics

American journal of health-system pharmacy, 2012-11, Vol.69 (21), p.1895-1904

2012

Volltextzugriff (PDF)

Antiretroviral Therapy

Infectious disease clinics of North America, 2014-09, Vol.28 (3), p.371-402

2014

Volltextzugriff (PDF)

Prolonged Infusions of β-Lactam Antibiotics: Implication for Antimicrobial Stewardship

Pharmacotherapy, 2012-08, Vol.32 (8), p.707-721

2012

Volltextzugriff (PDF)

Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN

Epilepsia (Copenhagen), 2012-01, Vol.53 (1), p.207-214

2012

Volltextzugriff (PDF)

Impact of Pharmacy Technician-Centered Medication Reconciliation on Optimization of Antiretroviral Therapy and Opportunistic Infection Prophylaxis in Hospitalized Patients With HIV/AIDS

Journal of pharmacy practice, 2013-08, Vol.26 (4), p.428-433

2013

Volltextzugriff (PDF)

Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir

Open forum infectious diseases, 2018-10, Vol.5 (10), p.ofy221

2018

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antiretroviral therapy: current drugs

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antibacterial Agents

Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents

A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression

Management of Antiretrovirals in Critically Ill Patients: Great Progress But Potential Pitfalls

Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort

Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran

Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine

The Effect of GS‐548351 on the Pharmacokinetics of Midazolam Following Multiple Doses of ANS‐6637 in Healthy Adults

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma

Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products

Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers

Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV‐Infected Patient Following Oral and Jejunostomy‐Tube Administration

Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?

National survey on continuous and extended infusions of antibiotics

Antiretroviral Therapy

Prolonged Infusions of β-Lactam Antibiotics: Implication for Antimicrobial Stewardship

Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN

Impact of Pharmacy Technician-Centered Medication Reconciliation on Optimization of Antiretroviral Therapy and Opportunistic Infection Prophylaxis in Hospitalized Patients With HIV/AIDS

Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir

Suchergebnisse filtern